Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add filters








Language
Year range
1.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 153-174, 2021.
Article in English | WPRIM | ID: wpr-900766

ABSTRACT

Dental implants are popular for dental rehabilitation after tooth loss. The goal of this systematic review was to assess bone changes around bone-level and tissue-level implants and the possible causes. Electronic searches of PubMed, Google Scholar, Scopus, and Web of Science, and a hand search limited to English language clinical trials were performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines up to September 2020. Studies that stated the type of implants used, and that reported bone-level changes after insertion met the inclusion criteria. The risk of bias was also evaluated. A total of 38 studies were included. Eighteen studies only used bone-level implants, 10 utilized tissuelevel designs and 10 observed bone-level changes in both types of implants. Based on bias assessments, evaluating the risk of bias was not applicable in most studies. There are vast differences in methodologies, follow-ups, and multifactorial characteristics of bone loss around implants, which makes direct comparison impossible. Therefore, further well-structured studies are needed.

2.
Journal of the Korean Association of Oral and Maxillofacial Surgeons ; : 153-174, 2021.
Article in English | WPRIM | ID: wpr-893062

ABSTRACT

Dental implants are popular for dental rehabilitation after tooth loss. The goal of this systematic review was to assess bone changes around bone-level and tissue-level implants and the possible causes. Electronic searches of PubMed, Google Scholar, Scopus, and Web of Science, and a hand search limited to English language clinical trials were performed according to PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analysis) guidelines up to September 2020. Studies that stated the type of implants used, and that reported bone-level changes after insertion met the inclusion criteria. The risk of bias was also evaluated. A total of 38 studies were included. Eighteen studies only used bone-level implants, 10 utilized tissuelevel designs and 10 observed bone-level changes in both types of implants. Based on bias assessments, evaluating the risk of bias was not applicable in most studies. There are vast differences in methodologies, follow-ups, and multifactorial characteristics of bone loss around implants, which makes direct comparison impossible. Therefore, further well-structured studies are needed.

3.
IJPR-Iranian Journal of Pharmaceutical Research. 2014; 13 (4): 1319-1325
in English | IMEMR | ID: emr-151751

ABSTRACT

Periodontitis [PD] is known to be one of most prevalent worldwide chronic inflammatory diseases. There are several treatments including antibiotics for PD; however, since drug resistance is an increasing problem, new drugs particularly derived from plants with fewer side effects are required. The effects of trans-anethole on IL[-1] beta and TNF-alpha level in a rat model of PD were investigated and compared to ketoprofen. Eschericia coli lipopolysaccharide [LPS, 30 microg] was injected bilaterally into the palatal gingiva [3 microL/site] between the upper first and second molars every two days for 10 days in anesthetized rats. Administration of either trans-anethole [10 or 50 mg/Kg, i.p.] or ketoprofen [10 mg/Kg, i.p.] was started 20 minute before LPS injection and continued for 10 days. Then, IL[-1]beta and TNF-alpha levels were measured in blood samples by ELISA at day 0 [control] and at day 10. Anethole at both concentrations significantly suppressed IL[-1]beta and TNF-alpha production when compared to LPS-treated rats. The suppressive effects of anethole on LPS-induced pro-inflammatory cytokines were almost similar as seen with ketoprofen. In conclusion, the present results suggest that anethole may have a potent inhibitory effect on PD through suppression of pro-inflammatory molecules; therefore it could be a novel therapeutic strategy for PD

SELECTION OF CITATIONS
SEARCH DETAIL